|
US4238607A
(en)
|
1972-06-19 |
1980-12-09 |
Endo Laboratories Inc. |
Pyridopyrrolo benzheterocycles
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
CH656884A5
(de)
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
|
ES2019275B3
(es)
|
1985-10-09 |
1991-06-16 |
Desitin Arzneimittel Gmbh |
Metodo para la produccion de una forma de administracion y de dosificacion para farmacos reactivos u otros principios activos.
|
|
HU208484B
(en)
|
1988-08-17 |
1993-11-29 |
Chinoin Gyogyszer Es Vegyeszet |
Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
|
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
|
US5538739A
(en)
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
|
CN1074923C
(zh)
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
|
PT1140012E
(pt)
|
1998-12-17 |
2004-05-31 |
Alza Corp |
Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
|
|
US6713471B1
(en)
|
1999-06-15 |
2004-03-30 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
|
ATE277048T1
(de)
|
1999-06-15 |
2004-10-15 |
Bristol Myers Squibb Pharma Co |
Substituierte hetercyclisch kondensierte gamma carboline
|
|
US7071186B2
(en)
|
1999-06-15 |
2006-07-04 |
Bristol-Myers Squibb Pharma Co. |
Substituted heterocycle fused gamma-carbolines
|
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
SK7042003A3
(en)
|
2000-12-20 |
2004-07-07 |
Bristol Myers Squibb Co |
Substituted pyridoindoles as serotonin agonists and antagonists
|
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
US7592454B2
(en)
|
2004-04-14 |
2009-09-22 |
Bristol-Myers Squibb Company |
Substituted hexahydro-pyridoindole derivatives as serotonin receptor agonists and antagonists
|
|
US20080194592A1
(en)
|
2005-08-23 |
2008-08-14 |
Intra-Cellular Therapies, Inc. |
Organic Compounds
|
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
KR102107954B1
(ko)
|
2007-03-12 |
2020-05-07 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
|
NZ586963A
(en)
|
2008-02-05 |
2012-11-30 |
Clera Inc |
Use of dopamine d2 receptor inhibitors for alleviating depression or improving cognition
|
|
AU2009223701B2
(en)
|
2008-03-12 |
2015-04-16 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines solid
|
|
EP3085231A1
(en)
|
2008-05-27 |
2016-10-26 |
Intra-Cellular Therapies, Inc. |
Method and compositions for sleep disorders and other disorders
|
|
CA2796756A1
(en)
|
2010-04-22 |
2011-10-27 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalines for the treatment of central nervous system disorders
|
|
TWI582092B
(zh)
|
2010-07-28 |
2017-05-11 |
歌林達股份有限公司 |
順式－四氫－螺旋（環己烷－１,１’－吡啶［３,４－b］吲哚）－４－胺－衍生物
|
|
DE102010041942B4
(de)
|
2010-10-04 |
2013-01-17 |
Lear Corporation |
Bewegliche Kopfstützen für Fahrzeugsitze
|
|
EP3153149B1
(en)
|
2011-08-16 |
2018-04-11 |
Tosho, Inc. |
Tablet splitting apparatus
|
|
KR20140146192A
(ko)
|
2012-04-14 |
2014-12-24 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
유기 화합물
|
|
AR092568A1
(es)
|
2012-09-14 |
2015-04-22 |
Abbvie Deutschland |
Derivados triciclicos de quinolinas y de quinoxalinas
|
|
US9708322B2
(en)
|
2013-03-15 |
2017-07-18 |
Intra-Cellular Therapies, Inc. |
Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity
|
|
CN105706016B
(zh)
|
2013-09-11 |
2019-07-19 |
欧力天工美国公司 |
用于时钟同步的系统、方法和移动设备
|
|
KR102373288B1
(ko)
|
2013-12-03 |
2022-03-10 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
신규한 방법
|
|
CA2944755A1
(en)
|
2014-04-04 |
2015-10-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
US10077267B2
(en)
|
2014-04-04 |
2018-09-18 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
WO2015191554A1
(en)
|
2014-06-09 |
2015-12-17 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of use to treat schizophrenia
|
|
WO2017117514A1
(en)
|
2015-12-31 |
2017-07-06 |
Tung Roger D |
Deuterated iti-007
|
|
PL3838274T3
(pl)
|
2016-01-26 |
2024-04-02 |
Intra-Cellular Therapies, Inc. |
Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
|
|
US20200392135A1
(en)
|
2016-03-25 |
2020-12-17 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
DK3407889T3
(da)
*
|
2016-03-25 |
2021-08-09 |
Intra Cellular Therapies Inc |
Organiske forbindelser og deres anvendelse til behandling og forebyggelse af lidelser i centralnervesystemet
|
|
EP3436455A4
(en)
|
2016-03-28 |
2019-09-04 |
Intra-Cellular Therapies, Inc. |
NOVEL SALTS AND CRYSTALS
|
|
US11014925B2
(en)
|
2016-03-28 |
2021-05-25 |
Intra-Cellular Therapies, Inc. |
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
|
|
PL3497104T3
(pl)
|
2016-08-09 |
2022-02-21 |
Teva Pharmaceuticals International Gmbh |
Postacie w stanie stałym soli ditosylanowej lumateperonu
|
|
EP3562484B1
(en)
|
2016-12-29 |
2021-08-25 |
Intra-Cellular Therapies, Inc. |
Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline derivatives useful in the treatment of cns disorders
|
|
WO2018126140A1
(en)
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
ES2926533T3
(es)
|
2017-03-17 |
2022-10-26 |
Scripps Research Inst |
Antagonistas del receptor opioideo kappa y productos y métodos relacionados con los mismos
|
|
RU2767410C2
(ru)
|
2017-03-24 |
2022-03-17 |
Интра-Селлулар Терапиз, Инк. |
Новые композиции и способы
|
|
EP3658144B1
(en)
|
2017-07-26 |
2022-01-26 |
Intra-Cellular Therapies, Inc. |
Pyridopyrroloquinoxaline compounds, their compositions and uses in therapy
|
|
WO2019023062A1
(en)
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
ORGANIC COMPOUNDS
|
|
CN112040940A
(zh)
|
2018-03-23 |
2020-12-04 |
细胞内治疗公司 |
有机化合物
|
|
EP3801527B1
(en)
|
2018-06-08 |
2025-02-19 |
Intra-Cellular Therapies, Inc. |
Fused gamma-carbolines for acute treatment of anxiety or depression
|
|
EP3833346A4
(en)
|
2018-08-08 |
2022-08-03 |
Torralva Medical Therapeutics LLC |
Compositions for opiate and opioid prevention and reversal, and methods of their use
|
|
US12195463B2
(en)
|
2018-12-21 |
2025-01-14 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
|
JP7649743B2
(ja)
|
2018-12-21 |
2025-03-21 |
イントラ－セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
|
US10668097B1
(en)
|
2019-03-21 |
2020-06-02 |
Direct Digital, LLC |
Testosterone enhancing compositions and methods
|
|
CA3134674A1
(en)
|
2019-04-04 |
2020-10-08 |
Intra-Cellular Therapies, Inc. |
Methods of treating neuropathic pain
|
|
JP7397095B2
(ja)
|
2019-05-07 |
2023-12-12 |
ニーサム・ラボラトリーズ・インコーポレイテッド |
オピオイド受容体アンタゴニストプロドラッグ
|